Please assess the completion status of the following clinical trial:

Trial Title: Knee Articular Cartilage Debridement in Conjunction With Partial Meniscectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:Screening~* Age between 18 and 60 years~* BMI \<35~* Meniscal tear (medial or lateral) diagnosed by H+P exam and/or imaging in the index knee~* No severe joint space narrowing (IKDC Classification) seen on weight-bearing AP X-ray in the index knee~* No avascular necrosis in the index knee as evidenced by preop MRI obtained within 6 months prior to randomization~* No Varus (\>10 degrees) or Valgus (\>15 degrees)knee deformities as seen by AP X-ray in the index knee~* Minimal or no abnormality of contralateral knee as shown by clinical exam and/or imaging~* Candidate for unilateral arthroscopic treatment of the knee~* Visual Analog Scale (VAS) pain score of 30 mm or greater in the index knee at the time of screening~* Must be able to undergo MRI at required time points per appendix D~* Physically and mentally willing and able to comply with study requirements~* Must be willing and able to follow the standardized rehabilitation protocol (Appendix C)~* Subject must sign IRB approved informed consent form~Arthroscopy Inclusion Criteria:~* Arthroscopic confirmation of ICRS Grade II or III chondral lesion on the medial or lateral femoral condyle~Exclusion Criteria: Screening~* Knee instability, malalignment, or patellar tracking dysfunction in the index knee~* Inflammatory rheumatoid arthritis or other systemic inflammatory arthritis in the index knee or contralateral knee~* Previous total meniscectomy in the index knee~* Previous surgical treatment of the index knee by arthroscopy less than 2 years prior to treatment by this study~* Previous total meniscectomy~* Previous knee tendon and/or ligament repair or patellar surgery of index knee~* Previous microfracture or bone marrow stimulation of the index knee~* Previous unsuccessful osteotomy in the index knee~* Presence of fractures, osteocysts or osteolysis in the index knee~* Presence of osteoarthritis in the index knee~* Pre-existent osteoarthritis of weight-bearing joints (e.g. hips or contralateral knee) that adversely affects gait~* Participation in another clinical study~* Terminally ill~* Drug therapy for the index knee with systemic steroid therapy, steroid intra-articular therapy or intra-articular hyaluronic acid therapy within 2 months of enrollment into this study~* Receiving narcotic pain medication by prescription for other conditions unrelated to knee injury~* Contralateral knee involvement causing abnormal ambulation and non-compliance with rehabilitation~* Pregnant or suspected pregnant~* Coagulation disorder or patient is receiving anti-coagulants, which cannot be safely stopped for 14 days (7 days prior to surgery and 7 days post-surgery)~Arthroscopy Exclusion Criteria:~* Presence of Grade IV chondromalacia anywhere in the index knee~* ACL, PCL or MCL tear of the index knee~* Osteochondritis dissecans (OCD)of the index knee~* Meniscal tear requiring total meniscectomy~* Evidence of osteoarthritis in the index knee

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Lavage debridement to remove loose fragments (Type: ACTIVE_COMPARATOR): Articular cartilage defect left untreated by surgical tool during partial meniscectomy
- Mechanical Debridement (Type: ACTIVE_COMPARATOR): Remove large chondral flaps and loose fragments
- RF based Debridement (Type: ACTIVE_COMPARATOR): Debridement to remove loose fragments followed by use of Paragon T-2 RF wand to smooth the base of the shoulder of the tear

Based on this trial design, predict the completion outcome and termination type (if applicable).